Dawn S Milliner is a member of the Divisions of Nephrology and Pediatric Nephrology, Departments of Internal Medicine and Pediatrics at the Mayo Clinic College of Medicine. She conducts research in pediatric stone disease, oxalate and inherited forms of nephrolithiasis. She chaired the Seventh International Workshop on Primary Hyperoxaluria, served as chair of the Scientific Advisory Board of the Oxalosis and Hyperoxaluria Foundation and is past President of the Research on Calculus Kinetics Society. She is the Medical Director for the Mayo Clinic, Hyperoxaluria Center and is Principal Investigator for the Rare Kidney Stone Consortium, funded by the NIH. Dawn S Milliner is a member of the Divisions of Nephrology and Pediatric Nephrology, Departments of Internal Medicine and Pediatrics at the Mayo Clinic College of Medicine. She conducts research in pediatric stone disease, oxalate and inherited forms of nephrolithiasis. She chaired the Seventh International Workshop on Primary Hyperoxaluria, served as chair of the Scientific Advisory Board of the Oxalosis and Hyperoxaluria Foundation and is past President of the Research on Calculus Kinetics Society. She is the Medical Director for the Mayo Clinic, Hyperoxaluria Center and is Principal Investigator for the Rare Kidney Stone Consortium, funded by the NIH.

Nephrology